Cloning and characterization of a lysosomal phospholipase A2, 1-O-acylceramide synthase
- PMID: 11790796
- DOI: 10.1074/jbc.M111977200
Cloning and characterization of a lysosomal phospholipase A2, 1-O-acylceramide synthase
Abstract
Recently, a novel enzyme, 1-O-acylceramide synthase (ACS), was purified and characterized from bovine brain. This enzyme has both calcium-independent phospholipase A(2) and transacylase activities. The discovery of this enzyme led us to propose a new pathway for ceramide metabolism in which the sn-2-acyl group of either phosphatidylethanolamine or phosphatidylcholine is transferred to the 1-hydroxyl group of ceramide. In this study, the partial amino acid sequences from the purified enzyme revealed that the enzyme contains amino acid sequences identical to those of human lecithin:cholesterol acyltransferase-like lysophospholipase (LLPL). The coding sequences of the mouse, bovine, and human genes were obtained from the respective kidney cDNAs by PCR. The open reading frames of LLPL were cloned into pcDNA3 to generate carboxyl-terminally tagged proteins. The expression of mouse LLPL in COS-7 cells demonstrated that transfected cells had higher transacylase and phospholipase A(2) activities than did non-transfected cells. Immunoprecipitation confirmed that LLPL had ACS activity. There were no significant lecithin:cholesterol acyltransferase and lysophospholipase activities in the mouse LLPL-transfected cells under either acidic or neutral conditions. Amino acid sequences from cDNAs of mouse, human, and bovine LLPLs demonstrated a signal peptide cleavage site, one lipase motif (AXSXG), and several N-linked glycosylation sites in each LLPL molecule. The replacement of serine with alanine in the lipase motif of mouse LLPL resulted in elimination of enzyme activity, indicating that the serine residue is part of the catalytic site. Deglycosylation of mouse, human, and bovine LLPLs yielded core proteins with a molecular mass of 42 kDa without change in enzyme activities. LLPL was post-translationally modified by signal peptide cleavage and N-linked glycosylation, and each mature LLPL had the same size core protein. Subcellular fractionation demonstrated that ACS activity co-localized with N-acetylglucosaminidase. Therefore, LLPL encodes a novel lysosomal enzyme, ACS.
Similar articles
-
A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity.Glycoconj J. 2004;20(1):25-32. doi: 10.1023/B:GLYC.0000016739.32089.55. Glycoconj J. 2004. PMID: 14973367 Review.
-
Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.J Biol Chem. 2004 Nov 19;279(47):48968-75. doi: 10.1074/jbc.M407841200. Epub 2004 Sep 10. J Biol Chem. 2004. PMID: 15364929
-
Structure and function of lysosomal phospholipase A2: identification of the catalytic triad and the role of cysteine residues.J Lipid Res. 2005 Nov;46(11):2441-7. doi: 10.1194/jlr.M500248-JLR200. Epub 2005 Aug 16. J Lipid Res. 2005. PMID: 16106046
-
Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.J Biol Chem. 2001 Mar 30;276(13):9838-45. doi: 10.1074/jbc.M010420200. Epub 2001 Jan 8. J Biol Chem. 2001. PMID: 11148210
-
Group XV phospholipase A₂, a lysosomal phospholipase A₂.Prog Lipid Res. 2011 Jan;50(1):1-13. doi: 10.1016/j.plipres.2010.10.006. Epub 2010 Nov 11. Prog Lipid Res. 2011. PMID: 21074554 Free PMC article. Review.
Cited by
-
A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity.Glycoconj J. 2004;20(1):25-32. doi: 10.1023/B:GLYC.0000016739.32089.55. Glycoconj J. 2004. PMID: 14973367 Review.
-
Lysosomal phospholipase A2.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):932-940. doi: 10.1016/j.bbalip.2018.07.012. Epub 2018 Aug 2. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 30077006 Free PMC article. Review.
-
Glycerophosphodiesters inhibit lysosomal phospholipid catabolism in Batten disease.Mol Cell. 2024 Apr 4;84(7):1354-1364.e9. doi: 10.1016/j.molcel.2024.02.006. Epub 2024 Mar 5. Mol Cell. 2024. PMID: 38447580 Free PMC article.
-
B-13 progenitor-derived hepatocytes (B-13/H cells) model lipid dysregulation in response to drugs and chemicals.Toxicology. 2017 Jul 1;386:120-132. doi: 10.1016/j.tox.2017.05.014. Epub 2017 May 26. Toxicology. 2017. PMID: 28552552 Free PMC article.
-
M05B5.4 (lysosomal phospholipase A2) promotes disintegration of autophagic vesicles to maintain C. elegans development.Autophagy. 2022 Mar;18(3):595-607. doi: 10.1080/15548627.2021.1943178. Epub 2021 Jun 30. Autophagy. 2022. PMID: 34130592 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases